Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins

Virology

Volumn 254, Issue 2, 1999, Pages 257-267

  Sugiura, Wataru ^a,b   Broder, Christopher C ^a,c   Moss, Bernard ^a   Earl, Patricia L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES;

EID: 0033557072     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9549     Document Type: Article

References (38)

1. Broder, C. C., and Berger, E. A. (1993). CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glyco-protein-mediated cell fusion. J. Virol. 67, 913-926.
2. Broder, C. C., and Berger, E. A. (1995). Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA 92, 9004-9008.
3. Broder, C. C., Earl, P. L., Long, D., Moss, B., and Doms, R. W. (1994). Antigenic implications of HIV-1 env quaternary structure. Proc. Natl. Acad. Sci. USA 91, 11699-11703.
4. Choe, H.-R., and Sodroski, J. (1995). Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid). J. Virol. 69, 2801-2810.
5. Daiss, J. L., and Scalice,. E. R. (1994). "epitope Mapping on BIAcore: Theoretical and Practical Considerations," pp. 143-156, A Companion to Methods in Enzymology, Vol. 6. New York, Academic Press, Inc.
6. Doms, R. W., and Moore, J. P. (1997). HIV-1 Coreceptor use: A molecular window into viral tropism. In "Human Retroviruses and AIDS" (B. Korber, B. Foley, T. Leitner, F. McCutchan, B. Hahn, J. W. Mellors, G. Myers, and C. Kuilen, eds.), Los Alamos, New Mexico.
7. Earl, P. L., Broder, C. C., Doms, R. W., and Moss, B. (1997). Epitope map of human immunodeficiency virus type-1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J. Virol. 71, 2674-2684.
8. Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., and Moss, B. (1994). Native oligomeric forms of human immunodeficiency virus type 1 envelope glycoprotein elicit a diverse array of monoclonal antibody reactivities. J. Virol. 68, 3015-3026.
9. Fouts, T. R., Binley, J. M., Trkola, A., Robinson, J. E., and Moore, J. P. (1997). Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71, 2779-2785.
10. Fouts, T. R., Trkola, A., Fung, M. S., and Moore, J. P. (1998). Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: Relationship to neutralization. AIDS Res. Human Retrov. 14, 591-597.
11. Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122-8126.
12. Ho, D. D., McKeating, J. A., Li, S. L., Moudgil, T., Daar, E. S., Sun, N.-C., and Robinson, J. E. (1991). Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65, 489-493.
13. Koito, A., Stamatatos, L., and Cheng-Mayer, C. (1995). Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology 206, 878-884.
14. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
15. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., III, Burton, D. R., and Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120 and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
16. Moore, J. P., and Ho, D. D. (1993). Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67, 863-875.
17. Moore, J. P., and Jarret, R. F. (1988). Sensitive ELISA for the gp120 and gp160 surface glycoprotein of HIV-1. AIDS Res. Human Retrov. 4, 369-379.
18. Moore, J. P., Sattentau, Q. J., Wyatt, R., and Sodroski, J. (1994). Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68, 469-484.
19. Moore, J. P., and Sodroski, J. (1996). Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70, 1863-1872.
20. Moore, J. P., Thali, M., Jameson, B. A., Vignaus, F., Lewis, G. K., Poon, S.-W., Charles, M., Fung, M. S., Sun, B., Durda, P. J., Akerblom, L., Wahren, B., Ho, D. D., Santtentau, Q. J., and Sodroski, J. (1993). Immunochemical analysis of the gp120 surface glycoprotein of human imunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67, 4785-4796.
21. Moore, J. P., Willey, R. L., Lewis, G. K., Robinson, J., and Sodroski, J. (1994). Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68, 6836-6847.
22. Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., and Sodroski, J. (1990). Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64, 5701-5707.
23. Otteken, A., Earl, P. L., and Moss, B. (1996). Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J. Virol. 70, 3407-3415.
24. Parren, P. W. H. I., Mondor, I., Naniche, D., Ditzel, H. J., Klasse, P. J., Burton, D. R., and Sattentau, Q. J. (1998). Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J. Virol. 72, 3512-3519.
25. Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H., and Byrn, R. A. (1991). An IgG human monoclonal antibody that reacts with HIV-1/gp120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 146, 4325-4332.
26. Reed, L. J., and Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
27. Richardson, T. M., Jr., Broder, C. C., Hoxie, J. A., Mascola, J. R., Earl, P. L., and Doms, R. W. (1996). The humoral response to oligomeric human immunodeficiency virus type I envelope protein. J. Virol. 70, 753-762.
28. Sattentau, Q. J., and Moore, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185-196.
29. Sattentau, Q. J., Zolla-Pazner, S., and Piognard, P. (1995). Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206, 713-717.
30. Stamatatos, L., and Cheng-Meyer, C. (1993). Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67, 5635-5639.
31. Steimer, K. S., Scandella, C. J., Skiles, P. V., and Haigwood, N. L. (1991). Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254, 105-108.
32. Thali, M., Furman, C., Ho, D. D., Robinson, J., Tilley, S., Pinter, A., and Sodroski, J. (1992). Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human imunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66, 5635-5641.
33. Weissenhorn, W., Wharton, S. A., Calder, L. J., Earl, P., Moss, B., Skehel, J. J., and Wiley, D. C. (1996). The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15, 1507-1514.
34. Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J., and Martin, M. A. (1988). In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62, 139-147.
35. Wyatt, R., Kwong, P. D., Desjardins, R., Sweet, R. W., Robinson, J., Hendrickson, W. A., and Sodroski, J. G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
36. Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., and Sodroski, J. (1995). Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes indiced by receptor binding. J. Virol. 69, 5723-5733.
37. Wyatt, R., Sullivan, N., Thali, M., Repke, H., Ho, D., Robinson, J., Posner, M., and Sodroski, J. (1993). Functional and immunological characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable region. J. Virol. 67, 4557-4565.
38. Wyatt, R., Thali, M., Tilley, S., Pinter, A., Posner, M., Ho, D., RobinSon, J., and Sodroski, J. (1992). Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to elements of the CD4 binding site. J. Virol. 66, 6997-7004.